Proinsulin C-peptide shows beneficial effects on microvascular complications of type 1 diabetes. However, the possible occurrence of membrane C-peptide receptor(s) has not been elucidated. The aim of this study was to identify and characterize membrane proteins to which C-peptide binds. The enzyme -enolase was co-immunoprecipitated with C-peptide after chemical cross-linking to HL-60 cell surface proteins, and identified by mass spectrometry. Recombinant -enolase activity was modulated by C-peptide, with a significant decrease in Km for 2-phosphoglycerate without affecting Vmax. The enzyme modulation by C-peptide was abolished when C-terminal basic lysine residue (K434) of the enzyme was replaced by neutral alanine or acidic glutamate, but not with basic arginine. The enzyme modulation by C-peptide was reproduced with the C-peptide fragments containing glutamate corresponding to position 27 (E27) of the full-length C-peptide. Addition of a lysine analogue to the assay and A31 cell culture abrogated the enzyme modulation and MAP kinase activation by C-peptide, respectively.
4 unlabeled native C-peptide (L-form) and its C-terminal pentapeptide (EGSLQ), but not by an all D-amino acid C-peptide, scrambled C-peptide, insulin, proinsulin or insulin-like growth factor I or II [23] . In line with their results, we have found that native C-peptide at sub-nM concentration, but not D-form and retro-sequenced C-peptide, enhances phosphorylation of p44/p42 mitogen-activated protein kinase (MAPK, Erk1/2) in fibroblasts and endothelial cells in culture [24] [25] [26] . As pertussis toxin treatment abolishes the C-peptide binding to membrane and also Erk phosphorylation [23, 24] , it is most probable that one of the putative receptors for C-peptide may be a G protein-coupled type of receptor. However, attempts to demonstrate the nature of the binding and the possible receptor structure have not been successful so far.
In the present study, we aimed to examine the molecular mechanisms of C-peptide´s cell membrane interaction in an attempt to identify and characterize membrane proteins to which C-peptide binds. We chose a human promyelocytic leukemia cell line to identify the proteins of interest, on the basis of the findings that C-peptide induces chemotaxis for monocytes and neutrophils in vitro [27, 28] , and found that the enzyme -enolase selectively interacted with C-peptide.
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Material and Methods
Chemotaxis assay with HL60 cells
HL60 cells, a human promyelocytic leukemia cell line, were maintained in RPMI1640 (Invitrogen Co., Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS, Trace Scientific Ltd., Melbourne, Australia). Chemotaxis assay was performed under serum-free conditions in a 96-well cell migration chamber (QCM TM 3 μm pore, Chemicon, Temecula, CA, USA). In brief, HL60 cells (1×10 6 cells/ml) were incubated in the serum-free medium for 16 hours and then aliquots (100 l each) were further incubated for 1 h in upper chamber wells, which were set on lower chamber wells containing the serum-free medium with phosphate-buffered saline (PBS), 10%
FBS, 10 nM human C-peptide (purity >95%, Eli Lilly Co., Indianapolis, IN, USA), 10 nM reverse sequence (retro)-human C-peptide (purity >95%, Bio-Synthesis, Inc., Lewisville, TX, USA) and 1 μg/ml interleukin-8 (Wako Pure Chemical Co., Osaka, Japan), respectively. The number of cells that migrated into the lower chamber wells was counted under a light microscope, according to the instructions provided.
Identification of the proteins specifically co-precipitated with C-peptide after chemical cross-linking
HL60 cells were extensively washed with the cold serum-free medium, and two sets of cells (10 6 cells each) were incubated with 10 nM human C-peptide at 4 °C for 1 [29] .
The supernatants (700 μg of protein each) were first incubated with 20 μl of protein G-sepharose (1:1 slurry, GE Healthcare, Little Chalfont, Buckinghamshire, UK)
for 2 h at 4 °C. After removal of the beads, the supernatants were incubated with anti-human C-peptide antibody (Biogenesis, Oxford, UK) for 16 h at 4 °C, followed by incubation with 20 μl of protein G-sepharose for 2 h at 4 °C. After washing the beads, they were incubated with 200 μl of the solution consisting of 8 M urea, 2% CHAPS, 0.5% ampholyte and 20 mM dithiothreitol for 30 min. The proteins were recovered by centrifugation at 5,000 x g for 10 min at 4 °C.
The proteins were first separated by isoelectric focusing using ZOOM IPG Strip (pH 3-10, non-linear, Invitrogen). The proteins were then separated by SDS-polyacrylamide gel electrophoresis and stained with silver staining kits (Wako for analysis and Pierce Silver SNAP for mass spectrometry) according to the instructions provided. The separated proteins in the two-dimensional gels were analyzed with PDQuest software (BioRad, Hercules, CA, USA). Mass spectrometric analysis of the protein of interest was outsourced to APRO Science (Tokushima, Japan).
RT-PCR
Total cellular RNA was isolated from the cultured cells and mouse tissues by the 7 guanidine-isothiocyanate method using RNAiso reagent (Takara Bio, Shiga, Japan). The RNA (2 µg) was treated at 76 °C for 10 min and reverse-transcribed using 100 units 
Preparation of recombinant native and mutant α-enolase proteins
Full-length human α-enolase cDNA was cloned from HL60 cells and its sequence was found to be identical to the reported sequence (GenBank accession number The cDNA for mutated α-enolase proteins (K434A, K434E, K434R) was generated by PCR using specific reverse primers and native human α-enolase cDNA as a template. Respective His-tagged mutated α-enolase proteins were produced as 11 described above. The primers used are summarized in Supplementary Table 2 .
Statistical analyses
The results are expressed as means  S.E.M. Statistical analyses were performed using ANOVA for experiments and Fischer's post hoc test and Student's t test, with p < 0.05 being considered statistically significant.
Results
To examine whether HL60 human promyelocytic leukemia cells respond to C-peptide, chemotaxis assay with the cells was performed. The cells migrated across the 3 m membrane to the lower chamber containing 10% FBS and IL-8 as a chemotactant, but not to the medium alone (control) (Fig. 1) . The cells also migrated to the lower chamber containing human C-peptide, while they did not respond to retro-sequenced C Fig. 2 ).
α-enolase is a rate-limiting enzyme in the glycolytic pathway, and therefore mainly located in the cytosol. However, recent studies have shown that α-enolase is also expressed on the cell surface of hematopoetic, epithelial and endothelial cells as a plasminogen receptor [31, 32] . In addition, it has been shown that the lysine residue present at the carboxy (C)-terminal end of α-enolase is important for 13 α-enolase-plasminogen interactions [31, 32] . Thus, we next examined site-specific ERK phosphorylation by C-peptide in A31 mouse fibroblastic cells, in which plasminogen activated the ERK pathway [33] . A31 cells expressed α-enolase mRNA, but not -and -enolases (ENO3 and ENO2) ( Supplementary Fig. 2 ), and α-enolase was labeled with membrane-impermeable biotinylation reagent ( Supplementary Fig. 3) . Treatment of the cells with either C-peptide or plasminogen activated ERK phosphorylation, which was abrogated by both prior treatment of carboxypeptidase B to remove C-terminal amino acid residues and inclusion of EACA as a competitor for lysine residue (Fig. 2) . These results suggested that cell surface molecule(s) containing basic amino acid(s) at the C-terminal, such as α-enolase, mediated signal transduction of C-peptide. In addition, ERK phosphorylation induced by C-peptide or plasminogen was abolished by prior treatment with pertussis toxin ( Supplementary Fig. 4 ).
Interestingly, C-peptide slightly enhanced α-enolase activity in A31 cell lysate ( Supplementary Fig. 5 ). Therefore, we measured recombinant α-enolase activity stoichiometrically in either the presence or the absence of C-peptide to examine the interaction between C-peptide and α-enolase. Native sequenced α-enolase (15 nM) converted 2-phosphoglycerate (2-PG) to phosphoenolpyruvate with Km of 1.14 ± 0.38 mM and maximal velocity (Vmax) of 29.3 ± 8.4 pmol/min. Human C-peptide (15 nM),
but not scrambled C-peptide, increased α-enolase activity at the 2-PG concentrations tested, with a significant decrease in Km value to 0.54 ± 0.02 mM, without affecting Vmax ( Fig. 3A and Table 1 ). Dose-response experiments of C-peptide revealed that an equimolecular amount of C-peptide to α-enolase was sufficient to fully modify the enzyme activity, suggesting that one molecule of C-peptide interacts with one molecule of the enzyme (Figs. 3B and 3C, and Table 1 ). This assumption was confirmed by the 14 fact that the addition of half the amount of C-peptide to α-enolase reduced Km value to 0.85 ± 0.12 mM as if only half the amount of the enzyme were modified by binding with C-peptide.
To determine whether the C-terminal lysine residue of α-enolase was involved in its interaction with C-peptide, the enzyme activity was measured in the presence or absence of C-peptide and EACA. Inclusion of EACA abolished C-peptide-induced enzyme modification, while it did not affect basal activity (Fig. 4A) , supporting the hypothesis. Furthermore, the mutant enzymes in which C-terminal lysine (basic amino acid, K434) was replaced with alanine (neutral amino acid, K434A) or glutamate (acidic amino acid, K434E) exhibited similar catalytic activity to the wild-type enzyme, although C-peptide failed to modify these enzyme activities (Figs. 4B and 4C ).
However, the activity of the mutant enzyme with arginine (basic amino acid, K434R)
replacing C-terminal lysine was enhanced by C-peptide, as observed in the wild-type enzyme (Fig. 4D) . Thus, the results indicate that the C-terminal lysine residue of α-enolase is essential for the stimulatory effect of C-peptide.
The glutamate residue at position 27 (E27) of C-peptide is suggested to be important for C-peptide binding to cell membranes [34] . To determine whether E27 of C-peptide was involved in its interaction with α-enolase, the enzyme activity was measured in the presence of C-peptide fragments. Among the fragments, peptides containing E27 (F2, F4 and F7) were as effective as the full-length peptide, although peptides without E27 (F5: E27 deletion and F6: E27A) were not (Figs. 3 and 5, Tables 1   and 2 ). In addition, peptides replaced E27 with aspartate and lysine (E27D and E27K)
were also failed to modulate the enzyme activity (data not shown). The fragments F1
and F3 containing a glutamate residue at positions of 1 and 3 tended to increase 15 α-enolase activity slightly, with a tendency for a decrease in both Km and Vmax values ( Fig. 5 and Table 2 ). Actually, there were differences in Vmax values between F1/F3 fragments and F2 pentapeptide (Table 2) . Furthermore, the retro-sequenced C-peptide as well as the fragment F3 increased wild-type and mutant (K434R) α-enolase activity, to a much lesser extent than that of the native C-peptide ( Supplementary Fig. 6 ). These results suggested that glutamate residues of C-peptide are involved in the modulation of the enzyme and that the glutamate residue at position 27 is essential for the stimulatory effect of C-peptide on α-enolase.
Discussion
In the present study, we have demonstrated for the first time that C-peptide enhances -enolase activity through the specific interaction between E27 of the peptide and K434 of the enzyme. This is based on the following findings: 1) -enolase activity was enhanced by full-length C-peptide, accompanied by a significant decrease in Km for the substrate without affecting Vmax, 2) excess amounts of C-peptide over the amounts of α-enolase (molar basis) were unproductive for the stimulatory effect of the peptide, 3) enhancement of-enolase activity by C-peptide was abolished when the C-terminal basic lysine residue (K434) of the enzyme was replaced with neutral alanine or acidic glutamate residue, while enhancement by C-peptide was observed for an enzyme in which the lysine residue had been replaced by arginine, 4) the enhancement by C-peptide was also abrogated by the presence of EACA (a lysine analogue), and 5) the peptides containing glutamate at position 27 (E27) of full-length C-peptide, but not the other peptides tested, enhanced -enolase activity in the same manner as full-length peptide.
Other than C-peptide, the peptide having the sequence of GMQGPAGSGWEEGSGSPPGVTPLFSP from acetylcholine esterase (AchE) variant R has been shown to increase α-enolase activity, but its level of activation is only 12% at 16-fold excess amounts of the peptide over the enzyme [35] . The study did not provide any detailed information on the AchE peptide-α-enolase interactions, thus the mechanism of the activation remains unknown. In contrast, two peptides (VGGSEI and LPQLTP) derived from C-reactive protein inhibit α-enolase activity by an unknown mechanism [36] . C-peptide at equi-molar ratio to α-enolase apparently enhanced the enzyme activity by almost 50% at the maximal substrate concentration tested, but actually decreased Km for the substrate of -enolase without affecting the maximal velocity. It is reported that active site of -enolase are composed of S39, D244, E292, and D317 in human -enolase [37] . In addition, the mutant enzymes in which C-terminal lysine residue (K434) was replaced with alanine or glutamate exhibited similar catalytic activity to the wild-type enzyme either in the absence or presence C-peptide. Since the assay system of the enzyme contains only -enolase, 2-phosphoglycerate (2-PG), and C-peptide, it is unlikely that C-peptide directly affect the active site of -enolase and the substrate itself. Thus, it is the most probably that C-peptide-induced decrease in Km is due to a conformational change of α-enolase by electrostatic specific interaction between E27 and K434, resulting in increase of apparent affinity to 2-PG. To clarify conformational changes in the enzyme structure by C-peptide like an allosteric activator, future studies involving the structural analysis of -enolase in the presence of C-peptide will be necessary.
Human C-peptide consists of 31 amino acid residues. The N-terminal region of C-peptide is shown to be essential for disaggregation of insulin oligomers and intramolecular chaperone-like activity for proinsulin folding [38] [39] [40] . The central region of C-peptide (i.e. residues 4-24 of human C-peptide) is suggested to be important for non-chiral membrane interaction [13] . This region consists largely of nonpolar amino acids flanking proline at position 16 and residues 9-12, 15-18 and 22-25 show tendencies to form -bends, while the N-terminal region forms a type I turn [40] .
C-terminal pentapeptide of human C-peptide (residues 27-31) presents the most well-defined structure of the whole molecule, including a type III' -turn [41] , and is highly conserved in mammalian species, although the amino acid sequences and number of residues of the C-peptides from different species are quite variable [42] . This C-terminal region is critical for the C-peptide binding to cell membrane [23] and subsequent activation of intracellular effectors, such as MAPK (Erk) as well as Na + , K + -ATPase [42, 43] , although the other regions also contribute to activation of these effectors to some extent [42, 43] . In the present study, the peptides containing E27
including full-length C-peptide enhanced -enolase activity by altering the apparent affinity for substrate without affecting maximal velocity, whereas the peptides containing N-terminal region of C-peptide having 2-3 glutamate residues (E1, E3, E11) and retro-sequenced C-peptide (E5, E21, E29, E31) modulated α-enolase activity in a different manner from that of the peptides containing E27. Thus, these results, taken together with the structural features of C-peptide, suggest that the structure of C-terminal pentapeptide is important for interaction between C-peptide and α-enolase, in addition to the electrostatic interaction between E27 and K434.
Other than α-enolase, C-peptide has been reported to interact with following proteins: insulin [38] [39] [40] , -chain of spectrin, myosin light chain kinase, cytoskeletal keratin type II, calcium/calmodulin-dependent serine protein kinase [44] , protein tyrosine phosphatase 1B [45] and histone H4 [46] . However, the molecular bases of these interactions remain obscure, with the exception of C-peptide-insulin interaction as described above [38] [39] [40] , and none of these is likely to engage with C-peptide-membrane interactions, although these proteins might be involved in the C-peptide signals and functions such as cell proliferation [46] . In contrast, it was previously shown that α-enolase is expressed on the cell surface of hematopoetic, epithelial and endothelial cells and serves as a plasminogen receptor [30] [31] [32] [33] , as well as on A31 cells in this study. Moreover, lysine residue present at the C-terminal of α-enolase including K434 is suggested to be important for plasminogen interaction with α-enolase and its cellular signaling. The present study showed that α-enolase was co-immunoprecipitated by C-peptide antibody, and that both C-peptide and plasminogen activated ERK phosphorylation in A31 cells, which was abrogated by prior treatments of carboxypeptidase B and pertussis toxin and by inclusion of EACA.
These results, taken together with the localization of α-enolase and its specific interaction with C-peptide, suggest that cell surface α-enolase is critical for pertussis toxin-sensitive signal transduction of C-peptide.
It is unlikely that the cell surface-enolase plays role in extracellular glycolytic activity, because 2-PG, the substrate of the enzyme, might be deficient in extracellular space. As suggested above, C-peptide interaction with α-enolase the most probably alters the enzyme conformation. Therefore, we assume that similar conformational changes of the enzyme in the absence of the substrate might be induced by C-peptide at the cell surface, and that such a conformational change in -enolase triggers signaling events for C-peptide. Unfortunately, our trials such as knockdown the enzyme expression in A31 and HL60 cells failed (data not shown), because α-enolase is the rate-limiting enzyme in the glycolytic pathway and, consequently, these cells did not grow. Thus, it is not possible to claim that α-enolase is the C-peptide receptor on the basis of the present evidence. Moreover, as several proteins such as p11 and TIP49a are also known as plasminogen receptors [47, 48] , some proteins other than α-enolase might also be involved in C-peptide-membrane interaction. Of course, there is a possibility that an unidentified pertussis toxin-sensitive G-protein-coupled receptor serves as a C-peptide receptor. However, the present results strongly suggest that α-enolase is a novel candidate for C-peptide receptor.
In summary, we have demonstrated that C-peptide modulates -enolase activity 20 through a specific interaction between E27 of the peptide and K434 of the enzyme. This C-peptide--enolase interaction is likely to occur on the cell surface, and might be of importance for signal transduction and the effects of C-peptide. 
